This movie requires Flash Player 8. Download Flash Player 8

Issue Features
View this issue online as it looks in print
Reason and Revelation Volume 28 #11

Adult Cells Still the Better Option for Therapeutic Research

For years, ethical issues have plagued the development of embryonic stem-cell research in America (cf. Bush, 2001). Despite its slight potential for therapeutic benefits in the distant future, embryonic stem-cell research has been shown to be unethical because it necessitates killing people (see Thompson and Harrub, 2001; cf. Gibson, 2007; Colley, 2007b). Scientists also have known for several years that adult stem-cell research has yielded greater results than embryonic stem-cell research (see Harrub and Thompson, 2004; Saunders and Prentice, 2006; “Stem Cell Research: Facts...,” 2001; Miller, 2007). Unlike embryonic stem cells, however, adult stem cells are only partially pluripotent, “capable of forming several cell types—principally blood, muscle, and nerve cells. It has been possible to recognize, select, and develop them to the point that they form mature cell types with the help of growth factors and regulating proteins” (Lillge, 2001; cf. “Stem Cell Basics,” 2006). In 2007, researchers determined that adult stem cells may be transformed into “blank slates that should be able to turn into any of the 220 cell types of the human body, be it heart, brain, blood or bone” (Kolata, 2007). This method allows for the development of truly pluripotent cells without resorting to “therapeutic” cloning or the destruction of embryos (see Kolata). Stem cells from adults may offer hope of developing therapies for patients suffering from diseases such as diabetes, Parkinson’s, and Alzheimer’s (see Takahashi, et al., 2007; cf. McIlroy, 2007; Colley, 2007a).

Not only have scientists changed adult stem cells into “iPS,” or pluripotent cells that carry the same possibilities for regenerative medicine as do embryonic stem cells (see Vogel and Holden, 2007), but now scientists have “transformed one type of fully developed adult cell directly into another inside a living animal” (Stein, 2008). Harvard biologists have “pinpointed three crucial molecular switches that, when flipped, completely convert a common [adult] cell in the pancreas into the more precious insulin-producing ones that diabetics need to survive” (Stein, bracketed item added; cf. Zhou, et al., 2007). This raises the possibility that “patients suffering from not only diabetes but also heart disease, strokes and many other ailments could eventually have some of their cells reprogrammed to cure their afflictions without the need for drugs, transplants or other therapies” (Stein). Zhou and colleagues discussed their research, in Nature:

Here...we identify a specific combination of three transcription factors (Ngn3 (also known as Neurog3) Pdx1 and Mafa) that reprograms differentiated pancreatic exocrine cells in adult mice into cells that closely resemble β-cells. The induced β-cells are indistinguishable from endogenous islet β-cells in size, shape and ultrastructure. They express genes essential for β-cell function and can ameliorate hyperglycaemia by remodelling [sic] local vasculature and secreting insulin. This study provides an example of cellular reprogramming using defined factors in an adult organ and suggests a general paradigm for directing cell reprogramming without reversion to a pluripotent stem cell state (2008, parenthetical items in orig., emp. added).

Researchers in the field of regenerative medicine have grand dreams of using adult cells to replace conventional surgery with a sort of genetic substitution (see Stein, 2008).

Those of us at Apologetics Press continue to pray that the Creator’s view of the matter will be paramount in the minds of those who push our society to new limits of biological inquiry. Embryonic stem-cell research is unscriptural and unethical. The scientific community is making it increasingly clear that embryonic stem-cell research is also unnecessary.


Bush, George W. (2001), “Remarks by the President on Stem-Cell Research,” [On-line], URL:

Colley, Caleb (2007a), “Adult Stem Cells Match the Potential of Embryonic Stem Cells,” [On-line], URL:

Colley, Caleb (2007b), “Therapeutic Embryonic Stem-Cell Research ‘Just Not Realistic’,” [On-line], URL:

Gibson, Robert (2007), “Stem Cell Research Is Good News for Heart Patients,” The Epoch Times, [On-line], URL:

Harrub, Brad and Bert Thompson (2004), “Presidential Elections, Superman, Embryonic Stem Cells, Bad Science, and False Hope,” [On-line], URL:

Kolata, Gina (2007), “Scientists Bypass Need for Embryo to Get Stem Cells,” The New York Times, [On-line], URL:

Lillge, Wolfgang (2001), “The Case for Adult Stem Cell Research,” 21st Century Science and Technology Magazine, [On-line], URL:

McIlroy, Anne (2007), “Stem-Cell Method Hailed as ‘Massive Breakthrough’,” The Globe and Mail, [On-line], URL:

Miller, Dave (2007), “Adult Stem-Cell Research,” [On-line], URL:

Saunders, William L., Jr., and David Prentice (2006), “Adult Stem Cell Treatments–Nine Faces of Success” (Washington, D.C.: Family Research Council), a tract.

Stein, Rob (2008), “Scientists Reprogram Adult Cells’ Function,” The Washington Post, [On-line], URL:

“Stem Cell Basics” (2006), The National Institutes of Health, [On-line], URL:

“Stem Cell Research: Facts and Fallacies” (2001), National Right to Life, [On-line], URL:

Takahashi, Kazutoshi, et al. (2007), “Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors,” Cell, 131:1-12, November, [On-line], URL:

Thompson, Bert and Brad Harrub (2001), “Human Cloning and Stem-Cell Research—Science’s ‘Slippery Slope’ [Part III],” [On-line], URL:

Vogel, Gretchen and Constance Holden (2007), “Field Leaps Forward With New Stem Cell Advances,” Science, 318:1224-1225, November 23.

Zhou, Qiao, et al. (2008), “In Vivo Reprogramming of Adult Pancreatic Exocrine Cells to β-Cells,” Nature, [On-line], URL:

Copyright © 2008 Apologetics Press, Inc. All rights reserved.

*Please keep in mind that Discovery articles are written for 3rd-6th graders.

This document may be copied, on the condition that it will not be republished in print unless otherwise stated below, and will not be used for any commercial purpose, as long as the following stipulations are observed: (1) Apologetics Press must be designated as the original publisher; (2) the specific Apologetics Press Web site URL must be noted; (3) any references, footnotes, or endnotes that accompany the article must be included with any written reproduction of the article; (4) textual alterations of any kind are strictly forbidden; (5) Some illustrations (e.g., photographs, charts, graphics, etc.) are not the intellectual property of Apologetics Press and as such cannot be reproduced from our site without consent from the person or organization that maintains those intellectual rights; (6) serialization of written material (e.g., running an article in several parts) is permitted, as long as the whole of the material is made available, without editing, in a reasonable length of time; (7) articles, excepting brief quotations, may not be offered for sale or included in items offered for sale; and (8) articles may be reproduced in electronic form for posting on Web sites pending they are not edited or altered from their original written content and that credit is given to Apologetics Press, including the web location from which the articles were taken. Further, documents may not be copied without source statements (title, author, journal title), and the address of the publisher and owner of rights, as listed below.

For catalog, samples, or further information, contact:

Apologetics Press
230 Landmark Drive
Montgomery, Alabama 36117
Phone (334) 272-8558

Web Store

Defending the Faith Study Bible

We are very excited to announce the NEW AP Defending the Faith Study Bible now available.

Featured Audio


Click the following link to visit our Multimedia section.

Featured Audio